Wellington Management Group LLP Cuts Stake in HCA Healthcare, Inc. $HCA

Wellington Management Group LLP lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 5.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,880,196 shares of the company’s stock after selling 230,117 shares during the quarter. Wellington Management Group LLP’s holdings in HCA Healthcare were worth $1,653,740,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Cerity Partners LLC boosted its position in shares of HCA Healthcare by 13.1% during the 3rd quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock valued at $18,719,000 after acquiring an additional 5,092 shares during the last quarter. Swiss National Bank grew its stake in shares of HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after buying an additional 23,100 shares in the last quarter. National Pension Service lifted its holdings in shares of HCA Healthcare by 2.9% in the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock valued at $267,051,000 after acquiring an additional 17,531 shares during the last quarter. Savant Capital LLC increased its stake in HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after acquiring an additional 1,246 shares during the last quarter. Finally, Sector Gamma AS lifted its stake in shares of HCA Healthcare by 36.0% in the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after purchasing an additional 2,883 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the sale, the senior vice president owned 44,379 shares in the company, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the transaction, the executive vice president directly owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 15,214 shares of company stock worth $7,797,595 in the last three months. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 0.2%

Shares of NYSE HCA opened at $533.39 on Friday. The firm has a market cap of $119.28 billion, a PE ratio of 18.79, a price-to-earnings-growth ratio of 1.63 and a beta of 1.34. HCA Healthcare, Inc. has a twelve month low of $313.21 and a twelve month high of $556.52. The business has a fifty day simple moving average of $507.05 and a two-hundred day simple moving average of $469.55.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the previous year, the company posted $6.22 earnings per share. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is 10.99%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on HCA. Truist Financial increased their price target on HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Robert W. Baird lifted their price target on shares of HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Oppenheimer increased their price objective on shares of HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $537.73.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.